HMC
Harvard Management Company’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-233,186
| Closed | -$3.1M | – | 28 |
|
|
2023
Q2 | $3.1M | Buy |
233,186
+4,042
| +2% | +$53.8K | 0.3% | 18 |
|
|
2023
Q1 | $2.65M | Hold |
229,144
| – | – | 0.28% | 30 |
|
|
2022
Q4 | $1.87M | Hold |
229,144
| – | – | 0.23% | 33 |
|
|
2022
Q3 | $1.33M | Hold |
229,144
| – | – | 0.17% | 40 |
|
|
2022
Q2 | $1.01M | Hold |
229,144
| – | – | 0.12% | 40 |
|
|
2022
Q1 | $2.09M | Hold |
229,144
| – | – | 0.21% | 37 |
|
|
2021
Q4 | $4.69M | Hold |
229,144
| – | – | 0.44% | 38 |
|
|
2021
Q3 | $5.86M | Buy |
+229,144
| New | +$5.86M | 0.34% | 28 |
|
|
2016
Q1 | – | Sell |
-50,630
| Closed | -$665K | – | 117 |
|
|
2015
Q4 | $665K | Buy |
+50,630
| New | +$665K | 0.06% | 80 |
|